Precursor T Cell Acute Lymphoblastic Leukemia Cn294276
Precursor T cell acute lymphoblastic leukemia is a fast-growing cancer of immature white blood cells. It occurs mainly in children and adolescents. Treatment typically requires intensive chemotherapy and may include stem cell transplant.
Key facts at a glance
- ICD-10
- C96.9
- ICD-11
- 2A00.0
- Body system
- hematologic
- Severity
- severe
- Chronic
- false
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Fatigue
(general)Generalized symptoms
(hematologic)Significant symptoms that substantially affect daily functioning.
Frequency: Varies
Pallor
(hematologic)Lymphadenopathy
(hematologic)Wheezing
(respiratory)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Intensive Multi-agent Chemotherapy
Aggressive chemotherapy protocol combining multiple drugs in sequential phases including induction, consolidation, and maintenance to achieve and maintain remission.
Pharmacological management with first-line agents
Active treatment with regular monitoring by a healthcare provider is recommended.
Allogeneic Hematopoietic Stem Cell Transplantation
Potentially curative approach using donor stem cells after myeloablative conditioning, particularly important for high-risk T-cell ALL or those with poor response to chemotherapy.
Additional treatment options
Minimal Residual Disease Assessment
Highly sensitive molecular and flow cytometry techniques to detect tiny numbers of leukemic cells below conventional detection limits, guiding treatment intensity decisions.
monitoringCNS-directed Therapy
Combination of intrathecal chemotherapy with or without cranial radiation specifically targeting sanctuary sites where standard chemotherapy penetrates poorly.
procedureMaintenance Chemotherapy
Prolonged lower-intensity chemotherapy lasting 2-3 years to eliminate residual disease and prevent relapse, typically using methotrexate and mercaptopurine with periodic vincristine pulses.
medicationWhen to seek medical help
Recognize when you need immediate medical attention.
See a doctor within 24 hours
Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.
Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.
Frequently asked questions
Common questions about this topic.
What is Precursor T Cell Acute Lymphoblastic Leukemia Cn294276?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines: T-Cell Acute Lymphoblastic Leukemia. J Natl Compr Canc Netw. 2023;21(5):245-262.
Ferrando AA, Look AT. Pathophysiology and management of precursor T-cell acute lymphoblastic leukemia. Blood Rev. 2020;34(4):100-115.
Daver N, Kantarjian H, Jabbour E, et al. Dasatinib with Hyper-CVAD in Newly Diagnosed T-Cell ALL: A Phase II Clinical Trial. J Clin Oncol. 2021;39(15_suppl):7010.
Sasaki K, Ravandi F, Kantarjian H, et al. A Systematic Review and Meta-Analysis of Blinatumomab for Relapsed/Refractory T-Cell ALL. Leukemia. 2022;36(9):2304-2315.
Medication Comparisons
Compare medications used to treat Precursor T Cell Acute Lymphoblastic Leukemia Cn294276. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy